FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2016

POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
DERMATOLOGY, VENEREOLOGY LEPROSY
PAPER III
DVD/J/16/06/III
Time 3 hours
Max. Marks 100
Important instructions:
• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. Various indices used in leprosy.
Steps of preparing and staining a slit smear in a case of lepromatous
leprosy.
6+4
2. Enumerate the rare presentations of leprosy.
Histoid leprosy.
Type III reactions.

3. What is the definition of a 'relapse' in leprosy?
What are the differences between a true relapse and a reversal
reaction?
How would you manage a case of relapse?

4. Enumerate the peripheral nerves involved in leprosy with
characteristic deformities caused due to their involvement.
Various pathomechanisms of oedema of feet in a case of
lepromatous leprosy.
6+4
5. IRIS in Anti-Retroviral Therapy (ART).
Management of tuberculosis in a patient receiving ART.
4+6
6. Jarisch-Herxheimer reaction in syphilis.
Dosage schedule in congenital syphilis
Prozone phenomenon.

7. Buschke Lowenstein tumour.
Papulonecrotic tuberculide of penis.
5+5
8. Discuss the following in context of counseling in HIV/AIDS:
Basic purpose.
Process of counseling.
Types of counseling.
Counseling in seronegative individuals.

P.T.O.
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2016

POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
DERMATOLOGY, VENEREOLOGY LEPROSY
PAPER III
9. Salient features of NACP IV.
10
10. Effect of pregnancy on HIV and vice versa.
Preventing of MTCT.
6
4